Atlas Trials

Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47

Clinical trial NCT00873431 · COMPLETED

Trial details

NCT number
NCT00873431
Sponsor
Valneva Austria GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pneumococcal Infections
Start date
2009-03-01
Primary completion
2010-02-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.